Krensavage Asset Management, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001609251 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 13, 2016

Total Value: $279M (100.0% shares, 0.0% debt)

Holdings (22)

BAXALTA INC 10.7%
Value $29.69M Shares 734,885 Est. Cost $31.68 Unrealized
OM2 ORTHOFIX INTERNATIONAL NV 9.6%
Value $26.7M Shares 643,145 Est. Cost $32.01 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 9.3%
Value $25.92M Shares 882,529 Est. Cost $37.95 Unrealized -26.6%
UTHR UNITED THERAPEUTICS CORP 8.9%
Value $24.9M Shares 223,445 Est. Cost $141.80 Unrealized -10.8%
TEVA TEVA PHARMACEUTICAL-SP ADR 7.6%
Value $21.11M Shares 394,519 Est. Cost $58.35 Unrealized
IMPAX LABORATORIES INC 6.8%
Value $18.82M Shares 587,882 Est. Cost $34.25 Unrealized
HALYARD HEALTH INC 5.8%
Value $16.16M Shares 562,289 Est. Cost $40.93 Unrealized
AMGEN INC 5.8%
Value $16.08M Shares 107,255 Est. Cost $152.20 Unrealized
RTI SURGICAL INC 4.9%
Value $13.79M Shares 3,447,090 Est. Cost $4.66 Unrealized
CNMD CONMED CORP 4.9%
Value $13.73M Shares 327,460 Est. Cost $37.99 Unrealized -7.2%
MRK MERCK & CO. INC. 4.9%
Value $13.56M Shares 256,222 Est. Cost $39.26 Unrealized -8.2%
INDIVIOR PLC 4.0%
Value $11.02M Shares 4,703,007 Est. Cost $3.34 Unrealized
INVACARE CORP 2.9%
Value $8.053M Shares 611,485 Est. Cost $15.64 Unrealized
ALLERGAN PLC 2.5%
Value $7.041M Shares 26,270 Est. Cost $303.07 Unrealized
SPECTRUM PHARMACEUTICALS INC 2.5%
Value $6.946M Shares 1,092,162 Est. Cost $6.64 Unrealized
DEPOMED INC 2.2%
Value $6.227M Shares 447,000 Est. Cost $16.75 Unrealized
SUCAMPO PHARMACEUTICALS-CL A 2.2%
Value $6.101M Shares 558,229 Est. Cost $14.50 Unrealized
BIOTA PHARMACEUTICALS INC 1.5%
Value $4.042M Shares 2,694,601 Est. Cost $2.11 Unrealized
DERMA SCIENCES INC 1.0%
Value $2.809M Shares 906,046 Est. Cost $4.57 Unrealized
DIGIRAD CORP 0.9%
Value $2.375M Shares 478,756 Est. Cost $4.41 Unrealized
JUNIPER PHARMACEUTICALS INC 0.7%
Value $1.897M Shares 286,967 Est. Cost $9.19 Unrealized
HILL-ROM HOLDINGS INC 0.6%
Value $1.732M Shares 34,442 Est. Cost $46.28 Unrealized